Dr Agarwals Eye Hospital Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Mar 2026 is 20.21% vs 23.67% in Mar 2025

Standalone Net Profit

YoY Growth in quarter ended Mar 2026 is 1.56% vs 25.02% in Mar 2025

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 6.77% vs 29.26% in Mar 2025

Interest

YoY Growth in quarter ended Mar 2026 is -32.18% vs 42.36% in Mar 2025

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025

Compare Quarterly Results Of Dr Agarwal's Eye With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

120.01

364.81

-244.80

-67.10%

Other Operating Income

0.00

Total Operating income

120.01

364.81

-244.80

-67.10%

Raw Material Cost

0.00

64.30

-64.30

-100.00%

Purchase of Finished goods

12.03

0.00

12.03

(Increase) / Decrease In Stocks

-0.90

0.00

-0.90

Employee Cost

23.96

74.18

-50.22

-67.70%

Power Cost

0.00

Manufacturing Expenses

29.88

96.59

-66.71

-69.07%

Selling and Distribution Expenses

0.00

Other Expenses

21.31

69.23

-47.92

-69.22%

Total Expenditure (Excl Depreciation)

86.28

304.30

-218.02

-71.65%

Operating Profit (PBDIT) excl Other Income

33.73

60.51

-26.78

-44.26%

Other Income

1.57

7.33

-5.76

-78.58%

Operating Profit (PBDIT)

35.30

67.84

-32.54

-47.97%

Interest

1.96

1.49

0.47

31.54%

Exceptional Items

0.00

Gross Profit (PBDT)

33.34

66.35

-33.01

-49.75%

Depreciation

12.09

11.34

0.75

6.61%

Profit Before Tax

21.25

55.01

-33.76

-61.37%

Tax

5.01

13.31

-8.30

-62.36%

Provisions and contingencies

0.00

Profit After Tax

16.24

41.70

-25.46

-61.06%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

16.24

41.70

-25.46

-61.06%

Equity Capital

4.83

91.67

-86.84

-94.73%

Face Value

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

33.62

4.55

29.07

638.90%

Diluted Earnings per share

33.60

4.55

29.05

638.46%

Operating Profit Margin (Excl OI)

28.11%

16.59%

0.00

11.52%

Gross Profit Margin

27.78%

18.19%

0.00

9.59%

PAT Margin

13.53%

11.43%

0.00

2.10%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 120.01 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 3.26% vs -1.27% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 20.21% vs 23.67% in Mar 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 16.24 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -6.02% vs -10.56% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 1.56% vs 25.02% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 33.73 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -1.86% vs -14.25% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 6.77% vs 29.26% in Mar 2025

Quarterly - Interest

Interest 1.96 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -3.45% vs -45.58% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -32.18% vs 42.36% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 28.11%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025